Poonglim Pharmatech

Poonglim Pharmatech signed an investment agreement on January 26, 2022, to build a fourth plant in the Saemangeum National Industrial Complex, investing 19.5 billion won on a 13,200 m² site. Construction will start in June 2022, with completion by 2024, creating 70 new jobs.

Poonglim Pharmatech signed an agreement to invest KRW 19.5 billion ($16.2 million) to construct a 4th plant on 132,000㎡ in Saemangeum Industrial Complex, South Korea, creating 70 jobs.

Poonglim Pharmatech began construction of a 17.8 billion won medical device plant in Saemangeum Industrial Complex, Gunsan, South Korea, to produce syringes, needles, and masks by 2022.

Poonglim Pharmatech signed an MOU with the Saemangeum Development Agency to invest 17.8 billion won in a new medical device and medical supply plant in Saemangeum Industrial Complex, South Korea. Construction is planned by 2021, creating 60 new jobs.